These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30098664)

  • 21. Loneliness in psychotic disorders and its association with cognitive function and symptom profile.
    Badcock JC; Shah S; Mackinnon A; Stain HJ; Galletly C; Jablensky A; Morgan VA
    Schizophr Res; 2015 Dec; 169(1-3):268-273. PubMed ID: 26527247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the 12-item World Health Organization disability assessment schedule 2.0 (WHODAS 2.0) onto the assessment of quality of life (AQoL)-4D utilities.
    Ma BH; Chen G; Badji S; Petrie D
    Qual Life Res; 2024 Feb; 33(2):411-422. PubMed ID: 37906346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian National Survey of Psychosis.
    Shah S; Mackinnon A; Galletly C; Carr V; McGrath JJ; Stain HJ; Castle D; Harvey C; Sweeney S; Morgan VA
    Schizophr Res; 2014 Oct; 159(1):20-6. PubMed ID: 25107848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.
    Hawthorne G; Osborne R
    Aust N Z J Public Health; 2005 Apr; 29(2):136-42. PubMed ID: 15915617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument.
    Hawthorne G
    Value Health; 2009 Sep; 12(6):948-57. PubMed ID: 19490558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis.
    Morgan VA; McGrath JJ; Jablensky A; Badcock JC; Waterreus A; Bush R; Carr V; Castle D; Cohen M; Galletly C; Harvey C; Hocking B; McGorry P; Neil AL; Saw S; Shah S; Stain HJ; Mackinnon A
    Psychol Med; 2014 Jul; 44(10):2163-76. PubMed ID: 24365456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments.
    Engel L; Chen G; Richardson J; Mihalopoulos C
    Qual Life Res; 2018 Nov; 27(11):2873-2884. PubMed ID: 30006664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.
    Zheng Q; Cox IA; de Graaff B; Campbell JA; Corte TJ; Glaspole I; Navaratnam V; Hopkins P; Zappala C; Ahmad H; Zhao T; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Jun; 32(6):1609-1619. PubMed ID: 36572788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument.
    Richardson J; Iezzi A; Peacock S; Sinha K; Khan M; Misajon R; Keeffe J
    Ophthalmic Epidemiol; 2012 Jun; 19(3):172-82. PubMed ID: 22568431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey.
    Pignon B; Schürhoff F; Szöke A; Geoffroy PA; Jardri R; Roelandt JL; Rolland B; Thomas P; Vaiva G; Amad A
    Schizophr Res; 2018 Mar; 193():336-342. PubMed ID: 28689754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.
    Campbell JA; Hensher M; Neil A; Venn A; Otahal P; Wilkinson S; Palmer AJ
    Pharmacoecon Open; 2018 Dec; 2(4):443-458. PubMed ID: 29623636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal population-based study of carers of people with psychosis.
    Poon AWC; Harvey C; Mackinnon A; Joubert L
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):265-275. PubMed ID: 26847994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data.
    Maxwell A; Özmen M; Iezzi A; Richardson J
    Qual Life Res; 2016 Dec; 25(12):3209-3219. PubMed ID: 27344318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata.
    Lai VWY; Chen G; Sinclair R
    J Dermatolog Treat; 2021 Mar; 32(2):250-257. PubMed ID: 31389731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.
    Hawthorne G; Richardson J; Osborne R
    Qual Life Res; 1999 May; 8(3):209-24. PubMed ID: 10472152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in people with psychotic disorders: The role of loneliness and its contributors.
    Nevarez-Flores AG; Breslin M; Carr VJ; Morgan VA; Waterreus A; Harvey C; Sanderson K; Neil AL
    Aust N Z J Psychiatry; 2022 Nov; 56(11):1421-1433. PubMed ID: 35075914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of global functioning and quality of life in people with psychotic disorders.
    Nevarez-Flores AG; Sanderson K; Breslin M; Carr VJ; Morgan VA; Neil AL
    Epidemiol Psychiatr Sci; 2019 Feb; 28(1):31-44. PubMed ID: 30270819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing multi-attribute utility instruments: CP-6D, a Cerebral palsy specific instrument, vs AQoL-4D.
    Bahrampour M; Downes M; Scuffham PA; Byrnes J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Mar; 22(2):217-224. PubMed ID: 33779449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.